High Resolution Mapping of Bactericidal Monoclonal Antibody Binding Epitopes on Staphylococcus aureus Antigen MntC.
The Staphylococcus aureus manganese transporter protein MntC is under investigation as a component of a prophylactic S.aureus vaccine. Passive immunization with monoclonal antibodies mAB 305-78-7 and mAB 305-101-8 produced using MntC was shown to significantly reduce S. aureus burden in an infant rat model of infection. Earlier interference mapping suggested that a total of 23 monoclonal antibodies generated against MntC could be subdivided into three interference groups, representing three independent immunogenic regions. In the current work binding epitopes for selected representatives of each of these interference groups (mAB 305-72-5 - group 1, mAB 305-78-7 - group 2, and mAB 305-101-8 - group 3) were mapped using Hydrogen-Deuterium Exchange Mass Spectrometry (DXMS). All of the identified epitopes are discontinuous, with binding surface formed by structural elements that are separated within the primary sequence of the protein but adjacent in the context of the three-dimensional structure. The approach was validated by co-crystallizing the Fab fragment of one of the antibodies (mAB 305-78-7) with MntC and solving the three-dimensional structure of the complex. X-ray results themselves and localization of the mAB 305-78-7 epitope were further validated using antibody binding experiments with MntC variants containing substitutions of key amino acid residues. These results provided insight into the antigenic properties of MntC and how these properties may play a role in protecting the hostagainst S. aureus infection by preventing the capture and transport of Mn2+, a key element that the pathogen uses to evade host immunity.
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Alexey V
AV
Gribenko
Pfizer Protein Engineering and Production, Cambridge, Massachusetts, United States of America.
Kevin
K
Parris
Pfizer Protein Engineering and Production, Cambridge, Massachusetts, United States of America.
Lidia
L
Mosyak
Department of Medicine, University of California at San Diego, La Jolla, California, United States of America.
Sheng
S
Li
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Luke
L
Handke
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Julio C
JC
Hawkins
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Elena
E
Severina
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Yury V
YV
Matsuka
Pfizer Vaccine Research and Development, Pearl River, New York, United States of America.
Annaliesa S
AS
Anderson
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16438-43
24019478
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7057-62
12773622
Biochemistry. 2005 Aug 23;44(33):11106-14
16101294
J Mol Recognit. 2012 Mar;25(3):114-24
22407975
J Infect Dis. 2012 Jun;205(11):1688-96
22474033
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
20383002
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
19461840
Biochemistry. 2009 Aug 4;48(30):7251-60
19588926
Mol Immunol. 2013 Oct;55(3-4):253-63
23498967
J Cell Biochem Suppl. 2001;Suppl 37:89-98
11842433
Protein Sci. 2002 Jun;11(6):1300-8
12021429
Science. 1986 May 23;232(4753):1001-4
2422757
J Mol Biol. 2012 Nov 9;423(5):789-99
22940366
PLoS One. 2015 Feb 26;10(2):e0116945
25719409
BMC Immunol. 2006 Apr 07;7:7
16603068
Methods Mol Biol. 2009;524:3-20
19377933
Curr Top Microbiol Immunol. 1999;243:23-36
10453636
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):368-80
22505257
Structure. 2015 Apr 7;23(4):713-23
25752540
PLoS One. 2013 Oct 28;8(10):e77874
24205007
J Mol Biol. 2003 Apr 11;327(5):1065-76
12662931
Proteins. 1993 Sep;17(1):75-86
8234246
Methods Enzymol. 1997;276:307-26
27754618
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3304-9
23396847
Curr Opin Biotechnol. 2001 Feb;12(1):59-64
11167074
Drug Discov Today. 2014 Jan;19(1):95-102
23928097
J Mol Biol. 2013 Sep 23;425(18):3429-45
23827136
Mol Microbiol. 2002 Jun;44(5):1269-86
12028379
Biochemistry. 2013 Aug 13;52(32):5491-502
23875785
Expert Rev Proteomics. 2011 Feb;8(1):43-59
21329427
J Thromb Haemost. 2013 Dec;11(12):2128-36
24152306
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4467-72
22392975
Adv Drug Deliv Rev. 2013 Jul;65(8):1020-30
23624418
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15477-82
16223878
Anal Chem. 2011 Sep 15;83(18):7129-36
21861454
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):751-6
14715906
Rapid Commun Mass Spectrom. 2009 Mar;23(5):639-47
19170039
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9848-52
1702219
Biochemistry. 2012 Dec 21;51(51):10127-36
23215256
Biotechnol Adv. 2010 Nov-Dec;28(6):849-58
20659548
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
J Virol. 2014 Jan;88(1):469-76
24155406
FASEB J. 2014 Apr;28(4):1644-53
24371123
Int J Hematol. 2011 Sep;94(3):241-7
21822587
Science. 2013 Nov 1;342(6158):592-8
24179220
J Mol Biol. 2011 Jun 24;409(5):853-66
21549714